Ethyl piperazine-2-carboxylate is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of various bioactive compounds. Its structural framework is particularly valuable in the development of drugs targeting neurological disorders, such as antipsychotics and antidepressants, due to its piperazine moiety, which often enhances binding affinity to receptor sites. Additionally, it serves as a building block in the creation of compounds with potential antimicrobial and antiviral properties, making it relevant in the fight against infectious diseases. Its role in medicinal chemistry also extends to the design of molecules for cancer therapy, where it contributes to the optimization of drug efficacy and selectivity. Beyond pharmaceuticals, it finds application in organic synthesis, aiding in the construction of complex molecules for research and industrial purposes.